ASTELLAS-015K-CL-RA22

Study Sponsor: Astellas

Study Title

A Phase 2b, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-finding, Multi-center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Patients

Medicine or Vaccine (generic name)

peficitinib hydrobromide

Sponsor Identification Number

015K-CL-RA22

Trial Registry Identification Number(#'s)

NCT01565655
EudraCT 2011-006020-20

Medical Condition

Rheumatoid Arthritis

Phase

Phase 2

Link to Astellas Study Register

https://www.clinicaltrials.astellas.com/study/?pid=015K-CL-RA22

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT01565655

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2011-006020-20

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

February 2020